The efficacy and safety of pegylated interferon α-2b-based immunotherapy for inactive hepatitis B surface antigen carriersOriginal Articles: Hepatology Published on 2023-10-142024-09-05 Journal: European Journal of Gastroenterology & Hepatology [Category] update2024, [키워드] HBsAg loss Immunotherapy inactive hepatitis B surface antigen carriers pegylated interferon α-2b [DOI] 10.1097/MEG.0000000000002627 PMC 바로가기 [Article Type] Original Articles: Hepatology